In this study, we sought to explore cyclic nucleotide-mediated tyrosine hydroxylase Ser40 phosphorylation as feasible therapeutic approach for addressing the motor symptoms in Parkinson’s disease. This evidence concerns the gene TH and Parkinson disease.